Skip to content

Clinical trials

Phase 3 Lung Diseases, Interstitial trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 3 Country / region: Argentina Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20172
20193
20201
20224
20232
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Terminated3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim8
United Therapeutics3
GlaxoSmithKline2
Kyntra Bio2
Bristol-Myers Squibb1
Gilead Sciences1
Insmed Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial18
Idiopathic Pulmonary Fibrosis5
Connective Tissue Diseases3
Pulmonary Fibrosis3
Idiopathic Interstitial Pneumonias2
Scleroderma, Diffuse2
Arthritis, Rheumatoid1
Autoimmune Diseases1
Fibrosis1
Hypertension, Pulmonary1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.